Randomized Study to Evaluate the Impact of Telemedicine Care in Patients With Type 1 Diabetes With Multiple Doses of Insulin and Suboptimal HbA1c in Andalusia (Spain): PLATEDIAN Study
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To assess the impact of a telemedicine visit using the platform Diabetic compared with a face-to-face visit on clinical outcomes, patients’ health-related quality of life (HRQoL), and physicians’ satisfaction in patients with type 1 diabetes. RESEARCH DESIGN AND METHODS: PLATEDIAN (Telemedicine on Metabolic Control in Type 1 Diabetes Mellitus Andalusian Patients) (NCT03332472) was a multicenter, randomized, 6-month follow-up, open-label, parallel-group controlled study performed in patients with type 1 diabetes with suboptimal metabolic control (HbA1c <8% [<64 mmol/mol]), treated with multiple daily injections. A total of 388 patients were assessed for eligibility; 379 of them were randomized 1:1 to three face-to-face visits (control cohort [CC]) (n = 167) or the replacement of an intermediate face-to-face visit by a telemedicine visit using Diabetic (intervention cohort [IC]) (n = 163). The primary efficacy end point was the mean change of HbA1c levels from baseline to month 6. Other efficacy and safety end points were mean blood glucose, glucose variability, episodes of hypoglycemia and hyperglycemia, patient-reported outcomes, and physicians’ satisfaction. RESULTS: At month 6, the mean change in HbA1c levels was −0.04 ± 0.5% (−0.5 ± 5.8 mmol/mol) in the CC and 0.01 ± 0.6% (0.1 ± 6.0 mmol/mol) in the IC (P = 0.4941). The number of patients who achieved HbA1c <7% (<53 mmol/mol) was 73 and 78 in the CC and IC, respectively. Significant differences were not found regarding safety end points at 6 months. Changes in HRQoL between the first visit and final visit did not differ between cohorts, and, regarding fear of hypoglycemia (FH-15 score ≥28), statistically significant differences observed at baseline remained unchanged at 6 months (P < 0.05). CONCLUSIONS: The use of telemedicine in patients with type 1 diabetes with HbA1c <8% (<64 mmol/mol) provides similar efficacy and safety outcomes as face-to-face visits.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Those persons with lower socioeconomic status have a higher risk for developing T2D, worse DM control, and more DM-related complications.1661–1663”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1662]
Citations
Cites
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Standards of Medical Care in Diabetes 2014
(2014) · Majmaah Journal of Health Sciences · doi:10.12816/0004790 · Cited by 1,465
Introduction: Standards of Medical Care in Diabetes—2018
(2018) · Diabetes Care · doi:10.2337/dc18-sint01 · Cited by 472
Charpentier, G., Benhamou, P.-Y., Dardari, D., Clergeot, A., Franc, S., Schaepelynck-Belicar, P., Catargi, B., Melki, V., Chaillous, L., Farret, A., et al. (2011) · Diabetes Care · doi:10.2337/dc10-1259 · Cited by 292
Faruque, L. I., Wiebe, N., Ehteshami-Afshar, A., Liu, Y., Dianati-Maleki, N., Hemmelgarn, B. R., Manns, B. J., & Tonelli, M. (2017) · Canadian Medical Association Journal · doi:10.1503/cmaj.150885 · Cited by 281
Tchero, H., Kangambega, P., Briatte, C., Brunet-Houdard, S., Retali, G.-R., & Rusch, E. (2019) · Telemedicine and e-Health · doi:10.1089/tmj.2018.0128 · Cited by 239
Telehealthcare for chronic obstructive pulmonary disease
McLean, S., Nurmatov, U., Liu, J. L., Pagliari, C., Car, J., & Sheikh, A. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007718.pub2 · Cited by 225
Zhai, Y.-K., Zhu, W.-J., Cai, Y.-L., Sun, D.-X., & Zhao, J. (2014) · Medicine · doi:10.1097/md.0000000000000312 · Cited by 221
Development and Validation of the Diabetes Quality of Life Brief Clinical Inventory
Burroughs, T. E., Desikan, R., Waterman, B. M., Gilin, D., & McGill, J. (2004) · Diabetes Spectrum · doi:10.2337/diaspect.17.1.41 · Cited by 209
SCHMITT, A. J., Reimer, A., Kulzer, B., Haak, T., Ehrmann, D., & Hermanns, N. (2015) · Diabetic Medicine · doi:10.1111/dme.12887 · Cited by 175
Rossi, M. C. E., Nicolucci, A., Di Bartolo, P., Bruttomesso, D., Girelli, A., Ampudia, F. J., Kerr, D., Ceriello, A., Mayor, C. D. L. Q., Pellegrini, F., et al. (2010) · Diabetes Care · doi:10.2337/dc09-1327 · Cited by 174
Wood, C. L., Clements, S. A., McFann, K., Slover, R. H., Thomas, J. F., & Wadwa, R. P. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0123 · Cited by 124 · cited 1×
“Moreover, it showed that absenteeism from school and work by patients and caregivers decreased and that adherence to appointments was higher (18).”
BackgroundTelemedicine in the Management of Type 1 Diabetes
Xu, T. T., Pujara, S., Sutton, S., & Rhee, M. K. (2018) · Preventing Chronic Disease · doi:10.5888/pcd15.170168 · Cited by 123 · cited 2×
“Furthermore, telemedicine has been associated with time savings, cost savings,highappointmentadherence rates, and high patient satisfaction (16).”
BackgroundLee, S. W. H., Ooi, L., & Lai, Y. K. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00330 · Cited by 117 · cited 4×
“The fear of hypoglycemia is associated with a reduction in insulin use, increased energy intake (15), and poor metabolic control.”
BackgroundResultInfluential15. Diabetes Advocacy: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s015 · Cited by 97
Telecare is a valuable tool for hypertension management, a systematic review and meta-analysis
Verberk, W. J., Kessels, A. G. H., & Thien, T. A. (2011) · Blood Pressure Monitoring · doi:10.1097/mbp.0b013e328346e092 · Cited by 86
Telemedicine consultation for patients with diabetes mellitus: A cluster randomised controlled trial
Sood, A., Watts, S. A., Johnson, J. K., Hirth, S., & Aron, D. C. (2018) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x17704346 · Cited by 86 · cited 1×
“These results are in line with previous studies conducted innoncontrolledpatientswith type1diabetes (HbA1c$8%or$64mmol/ mol),whichdemonstrated improvingHbA1c without significant differences between the CC and the IC (15,27).”
ResultEsmatjes, E., Jansà, M., Roca, D., Pérez-Ferre, N., del Valle, L., Martínez-Hervás, S., Ruiz de Adana, M., Linares, F., Batanero, R., Vázquez, F., et al. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0313 · Cited by 64 · cited 1×
“Earlier experiences of telemedicine in type 1 diabetes management suggested that its utilization is less costly and more efficient than face-to-face visits (17).”
Carral, F., Ayala, M. D. C., Fernández, J. J., González, C., Piñero, A., García, G., Cañavate, C., Jiménez, A. I., & García, C. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0223 · Cited by 64 · cited 1×
“The Diabetic platform has been assessed in previous studies on telemedicine with successful outcomes (21).”
BackgroundSelf-citationDevelopment of a new Fear of Hypoglycemia Scale: FH-15.
Ortiz, M. T. A., Caballero, F. F., de Adana, M. S. R., Rondán, R. M., Carreira, M., Domínguez‐López, M., Machado, A., Gonzalo‐Marín, M., Tapia, M. J., Valdés, S., et al. (2011) · Psychological Assessment · doi:10.1037/a0021927 · Cited by 64 · cited 1×
“The Fear of Hypoglycemia (FH-15) questionnaire assesses the fear of hypoglycemia in adult patients with type 1 diabetes (24).”
BackgroundImproved A1C Levels in Type 1 Diabetes with Smartphone App Use
Ryan, E. A., Holland, J., Stroulia, E., Bazelli, B., Babwik, S. A., Li, H., Senior, P., & Greiner, R. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2016.06.001 · Cited by 63 · cited 2×
“In prior studies, monitoring glucose records and providing insulin dose adjustments using telemedicine systems proved effective in reducing HbA1c in patients with poor glycemic control (HbA1c$8% [$64mmol/mol]) (3,6,7).”
BackgroundMethodBartolo, P. D., Nicolucci, A., Cherubini, V., Iafusco, D., Scardapane, M., & Rossi, M. C. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-0963-4 · Cited by 49
Klonoff, D. C. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600301 · Cited by 36
Choleau, C., Aubert, C., Cahané, M., & Reach, G. (2008) · Diabetes & Metabolism · doi:10.1016/j.diabet.2007.12.002 · Cited by 23
Soidán, F. J. G., Villoro, R., Merino, M., Hidalgo‐Vega, Á., Hernando-Martín, T., & González-Martín-Moro, B. (2016) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2016.06.004 · Cited by 13
Research works printed but not linked: 4
- World Health Organization, 2010, Telemedicine: Opportunities and Developments in Member States: Report on the Second Global Survey on eHealth 2009
- European Medicines Agency, 2016, Guideline for Good Clinical Practice E6(R2), 1
- Ruiz de Adana, 2012, High inflammatory markers in subjects with type 1 diabetes and its relationship with diabetes-related complications and insulin treatment, Av Diabetol, 28, 1
- StataCorp, 2015, Stata Statistical Software: Release 14
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Grunberger, G., Sherr, J., Allende, M., Blevins, T., Bode, B., Handelsman, Y., Hellman, R., Lajara, R., Roberts, V. L., Rodbard, D., et al. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.04.008 · Cited by 288
Adoption of Telemedicine for Type 1 Diabetes Care During the COVID-19 Pandemic
Lee, J. M., Carlson, E. J., Albanese-O’Neill, A., Demeterco‐Berggren, C., Corathers, S. D., Vendrame, F., Weinstock, R. S., Prahalad, P., Alonso, G. T., Kamboj, M. K., et al. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0080 · Cited by 82
Ahmadiankalati, M., Steins-Loeber, S., & Paslakis, G. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00568 · Cited by 56
Physician Satisfaction With Telehealth: A Systematic Review and Agenda for Future Research
Hoff, T., & Lee, D.-R. (2022) · Quality Management in Health Care · doi:10.1097/qmh.0000000000000359 · Cited by 61
Metadata
- Authors
- Ruiz de Adana, M. S., Alhambra-Expósito, M. R., Muñoz-Garach, A., Gonzalez-Molero, I., Colomo, N., Torres-Barea, I., Aguilar-Diosdado, M., Carral, F., Serrano, M., Martínez-Brocca, M. A., Duran, A., & Palomares, R.
- Affiliations
- Endocrinology and Nutrition Department, Hospital Regional Universitario de Málaga, Málaga, Spain
- Endocrinology and Nutrition Department, Hospital Universitario Reina Sofía, Córdoba, Spain
- Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain
- Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (ES)
- Hospital Universitario de Jerez (ES)
- Endocrinology and Nutrition Department, Hospital Universitario Puerta del Mar, Cádiz, Spain
- Hospital Universitario Puerto Real (ES)
- Complejo Hospitalario de Jaén (ES)
- Endocrinology and Nutrition Department, Hospital Universitario Virgen Macarena, Sevilla, Spain
- Sanofi (Spain) (ES)
- Instituto Maimónides de Investigación Biomédica de Córdoba (ES)
- Corresponding author
- Colomo, Natalia
- ORCID
- Colomo, Natalia
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2019-12-12
- Volume
- 43
- Issue
- 2
- Pages
- 337-342
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2996438223
- Cited by
- 53
- References
- 25
- Citations by year
- 2025: 5 · 2024: 13 · 2023: 10 · 2022: 10 · 2021: 8 · 2020: 7
- FWCI
- 5.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- RISalud Institutional Health Repository of Andalucía (submittedVersion)
- Funders
- Andalusian Society of Endocrinology, Diabetes, and Nutrition
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- telemedicine, HbA1c, glycemic control, multiple daily insulin injections, health-related quality of life, fear of hypoglycemia, hypoglycemia, glycemic variability, physician satisfaction, Andalusia, patient-reported outcomes
- MeSH terms
- Adult, Blood Glucose, Diabetes Mellitus, Type 1, Dose-Response Relationship, Drug, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Hypoglycemia, Hypoglycemic Agents, Injections, Insulin, Male, Middle Aged, Office Visits, Primary Health Care, Quality of Life, Spain, Treatment Outcome, Telemedicine, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.